Avian Influenza
New bird flu drug promises to beat the problem of resistance
Published in TB and Outbreaks Week, August 29th, 2006
Dr Andrew Watts from the University of Bath (U.K.) and Dr Jennifer McKimm-Breschkin from CSIRO (Australia) have been awarded over £408,000 from the Medical Research Council (MRC) to develop a new class of inhibitor they have discovered into a new kind of antiviral influenza drug.
The search for an alternative flu drug has become all the more pressing as the full extent of resistance - the ability of the influenza virus to withstand drug treatments - becomes more...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Avian Influenza
Avian influenza virus A/chicken/Yamaguchi/7/04 (H5N1) strain highly pathogenic to other birds - Norovirus Outbreaks
Noroviruses are an important cause of gastroenteritis in Taiwan - Tuberculosis Epidemiology
Tuberculosis infectiousness of initial case associated with higher rate of cluster growth - Antimicrobials
Bisbenzamidine derivatives active against Pneumocystis pneumonia and less toxic than pentamidine - Antituberculosis Toxicity
Hepatotoxicity self-limiting after short-course therapy for latent tuberculosis - Aspergillus Endophthalmitis Treatment
Intravitreal voriconazole successfully treats Aspergillus endophthalmitis infection - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
